Cancer Updates
Cancer news from the American Cancer Society.
Filtering by:
Lung CancerFDA Approves Tecentriq (Atezolizumab) for Small Cell Lung Cancer
Published on: March 19, 2019
The US Food and Drug Administration (FDA) has approved the immunotherapy drug Tecentriq (atezolizumab) for the treatment of small cell lung cancer (SCLC).
Lung Cancer Screening Guideline: Frequently Asked Questions
Published on: January 24, 2019
The American Cancer Society lung cancer screening guidelines recommend yearly low dose CT (LDCT) for certain people at higher risk of lung cancer that meet several conditions.
Lung Cancer Screening Guidelines for Current or Former Smokers
Published on: January 24, 2019
American Cancer Society guidelines recommend yearly lung cancer screening for people who meet certain criteria that put them at higher risk for developing the disease.
FDA Approves Vitrakvi (Larotrectinib) for Tumors With Certain Genetic Change
Published on: November 28, 2018
For the second time, the US Food and Drug Administration (FDA) has approved a drug to treat tumors with a specific genetic change regardless of the type of cancer. Vitrakvi (larotrectinib) is for adults and children with solid tumors that test positive for NTRK genes, which can help cancerous tumors grow.
FDA Approves Opdivo (Nivolumab) for Small Cell Lung Cancer
Published on: August 17, 2018
The US Food and Drug Administration had approved the immunotherapy drug Opdivo (nivolumab) to treat people with small cell lung cancer (SCLC).